Sectors

BRKR
Bruker Corporation
58.44
1 x 54.75
1 x 61.00
bid
ask
+
3.33
6.04%
1 @ 04:10 PM
58.44 +0.00 (0.00%)
Ytd 24.05%
1y 47.35%
55.49
day range
58.57
28.53
52 week range
64.54
Open 55.89 Prev Close 55.11 Low 55.49 High 58.57 Mkt Cap 8.90B
Vol 1.82M Avg Vol 2.40M EPS -0.24 P/E N/A Forward P/E 23.99
Beta 1.30 Short Ratio 5.07 Inst. Own 92.81% Dividend 0.20 Div Yield 0.36
Ex Div Date 06-22 Earning 08-04 50-d Avg 46.67 200-d Avg 42.12 1yr Est 53.83
Earning
Date For Estimate Reported Surprise surprise %
2026-05-06 2026-03 0.23 0.31 0.08 34.78%
2026-02-12 2025-12 0.65 0.59 -0.06 -9.23%
2025-11-03 2025-09 0.33 0.45 0.12 36.36%
2025-08-04 2025-06 0.33 0.32 -0.01 -3.03%
2025-05-07 2025-03 0.46 0.47 0.01 2.17%
2025-02-13 2024-12 0.75 0.76 0.01 1.33%
Upgrade / Downgrade
Date Firm Action From To
2026-06-24 Barclays Upgrade Overweight Overweight
2026-06-08 JP Morgan Upgrade Overweight Overweight
2026-05-07 UBS Upgrade Neutral Neutral
2026-05-07 Citigroup Upgrade Neutral Neutral
2026-05-07 TD Cowen Upgrade Hold Hold
2026-05-07 Barclays Upgrade Overweight Overweight
Profile
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Insider Holder
Date Name Relation Quantity Description
2025-08-14 BUSSE FALKO Officer 48.17K Stock Award(Grant)
2025-08-14 HERMAN GERALD N Chief Financial Officer 102.58K Stock Award(Grant)
2025-08-14 LAUKIEN FRANK H Chief Executive Officer 40.50M Stock Award(Grant)
2026-02-12 LINTON WILLIAM A. Director 63.24K Stock Award(Grant)
2026-06-14 MUNCH MARK ROBERT Officer 128.44K Sale
2026-02-12 ORNELL JOHN A Director 39.73K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Orbis Allan Gray Ltd 17.94M 1.05B 11.79%
2026-03-30 FMR, LLC 16.10M 940.99M 10.58%
2026-03-30 Blackrock Inc. 11.18M 653.41M 7.34%
2026-03-30 Pallas Capital Advisors Llc 9.48M 554.12M 6.23%
2026-03-30 Vanguard Portfolio Management LLC 4.86M 283.78M 3.19%
2026-03-30 Vanguard Capital Management LLC 4.82M 281.51M 3.16%
Fund Ownership
Report Date Organization Position Value Percentage
2026-05-30 iShares Trust-iShares Core S&P Mid-Cap ETF 3.76M 219.93M 2.47%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 3.39M 197.94M 2.23%
2026-04-29 Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. 2.61M 152.47M 1.71%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 2.45M 143.32M 1.61%
2026-04-29 Fidelity Hastings Street Trust-Fidelity Series Large Cap Stock Fund 2.36M 137.82M 1.55%
2026-05-30 First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. 2.05M 120.09M 1.35%
Dividend
Dividend Date
0.05 2026-06-22
0.05 2026-03-23
0.05 2025-12-08
0.05 2025-09-23
0.05 2025-06-16
0.05 2025-03-17